NeuroSense receives US patent for Alzheimer's treatment through 2043
Go back to NeuroSense receives US patent for Alzheimer's treatment through 2043| (NASDAQ: NRSN) | Delayed: 0.36 +0.01 (2.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.35 | 52 Week High | $ | |||
| Open | $0.36 | 52 Week Low | $ | |||
| Day High | $0.39 | P/E | N/A | |||
| Day Low | $0.35 | EPS | $ | |||
| Volume | 23,739 | |||||
| (NASDAQ: NRSNW) | Delayed: 0.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.05 | 52 Week High | $ | |||
| Open | $0.05 | 52 Week Low | $ | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.05 | EPS | $ | |||
| Volume | 6 | |||||
